Licoisoflavone B and glabridin from Glycyrrhiza glabra as potent nucleoprotein antagonists of Lassa virus: insights from molecular docking, dynamics simulation, PCA, and DFT studies. [PDF]
Faisal Ahmed S +5 more
europepmc +1 more source
A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs. [PDF]
Carey BD +19 more
europepmc +1 more source
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines. [PDF]
Reed NS +12 more
europepmc +1 more source
Identification of a macrocyclic compound targeting the lassa virus polymerase. [PDF]
Aida-Ficken V +9 more
europepmc +1 more source
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry. [PDF]
Zhang Z +12 more
europepmc +1 more source
Modelling Lassa virus dynamics in West African Mastomys natalensis and the impact of human activities. [PDF]
John RS, Fatoyinbo HO, Hayman DTS.
europepmc +1 more source
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. [PDF]
Cooper CL +37 more
europepmc +1 more source
Molecular phylogeny of Guanarito virus, an emerging arenavirus affecting humans [PDF]
Gonzalez, Jean-Paul +2 more
core
Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch. [PDF]
Guo J +6 more
europepmc +1 more source

